NutriBand (NTRB) Common Equity (2016 - 2026)
NutriBand (NTRB) reported Common Equity of $5.33 million for fiscal Q2 2027 (quarter ended Jul 31, 2026), down 37.3% from $8.49 million a year earlier and down 11.0% from the prior quarter.
Powered by 
Analysis
NutriBand (NTRB) Common Equity (2016 - 2026) Analysis & Trends
At the end of FY2026 (ended Jan 31, 2026), NutriBand posted Common Equity of $6.68 million, up 3.9% from FY2025.
- Common Equity has a five-year compound annual growth rate of -1.2% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $6.43 million in FY2025 (-0.1%), $6.44 million in FY2024 (-24.9%), $8.57 million in FY2023 (-27.7%) and $11.86 million in FY2022 (+66.8%).
- The fiscal Q2 2027 figure ranks as the lowest quarterly Common Equity since fiscal Q1 2026.
- Year over year, Common Equity gained in three of the last eight quarters, with an average decline of 5.7%.
- The high point for year-over-year Common Equity in five years was fiscal Q3 2022 (growth of 97.4%); the low point was fiscal Q1 2026 (a decline of 61.8%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $5.99 million (Q1 2027), $6.68 million (Q4 2026) and $7.55 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.68 Bn | 1,105.26 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 617.43 Bn | 535.95 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 501.53 Bn | 474.64 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.54 Bn | 261.53 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 260.75 Bn | 234.43 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.10 Bn | 165.30 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 85.49 Bn |
| 10 | NutriBand | 75.37 Mn | 58.05 Mn | 181,874.00 | 5.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 5.33 Mn |
| Apr 30, 2026 | 5.99 Mn |
| Jan 31, 2026 | 6.68 Mn |
| Oct 31, 2025 | 7.55 Mn |
| Jul 31, 2025 | 8.49 Mn |
| Apr 30, 2025 | 5.10 Mn |
| Jan 31, 2025 | 6.43 Mn |
| Oct 31, 2024 | 11.23 Mn |
| Jul 31, 2024 | 12.46 Mn |
| Apr 30, 2024 | 13.36 Mn |
| Jan 31, 2024 | 6.44 Mn |
| Oct 31, 2023 | 5.71 Mn |
| Jul 31, 2023 | 6.89 Mn |
| Apr 30, 2023 | 7.72 Mn |
| Jan 31, 2023 | 8.57 Mn |
| Oct 31, 2022 | 9.73 Mn |
| Jul 31, 2022 | 10.40 Mn |
| Apr 30, 2022 | 11.08 Mn |
| Jan 31, 2022 | 11.86 Mn |
| Oct 31, 2021 | 14.32 Mn |
API Access
NutriBand Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NTRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NTRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NTRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();